HeartWare International Inc

Type: Company
Name: HeartWare International Inc
First reported 6 hours ago - Updated 6 hours ago - 1 reports

Developing the ‘heartware’ for a Smart Nation

Singapore is making a big push to become the world’s first Smart Nation.“Our goal is to establish Singapore as a Smart Nation that taps the potential of infocomm and media (ICM) and that nurtures innovative talent and enterprises. In this way, the ICM ... [Published Today Online - 6 hours ago]
First reported 12 hours ago - Updated 12 hours ago - 1 reports

HeartWare : Reports Outline Cardiology Study Findings from University of Leipzig (A minimally invasive off-pump implantation technique for continuous-flow left...

Reports Outline Cardiology Study Findings from University of Leipzig (A minimally invasive off-pump implantation technique for continuous-flow left ventricular assist devices: Early experience)By a News Reporter-Staff News Editor at Cardiovascular Week ... [Published 4 Traders - 12 hours ago]
First reported Aug 22 2014 - Updated Aug 23 2014 - 4 reports

First patient with Heartware artificial heart out of hospital

A 39-year-old man, the first patient in Vietnam to have a synthetic heart device (Heartwear) implanted in his chest, was discharged from the hospital on August 22nd... ... [Published People's Army Newspaper Online - Aug 23 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

Insider Selling: HeartWare International Director Unloads 1,000 Shares of Stock (HTWR)

HeartWare International (NASDAQ:HTWR) Director Robert Bain Thomas sold 1,000 shares of the stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $81.97, for a total value of $81,970.00. Following the transaction, ... [Published American Banking News - Forex - Aug 21 2014]
First reported Aug 20 2014 - Updated Aug 21 2014 - 2 reports

Insider Selling: Jeffrey Larose Sells 2,179 Shares of HeartWare International Stock (HTWR)

HeartWare International (NASDAQ:HTWR) Insider Jeffrey Larose sold 2,179 shares of the company’s stock on the open market in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $81.51, for a total value of $177,610.29. Following ... [Published American Banking News - Forex - Aug 21 2014]
First reported Aug 13 2014 - Updated Aug 13 2014 - 1 reports

HeartWare International announces appointment of Katrin Leadley, M.D., as chief medical officer

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced the appointment of Katrin Leadley, M.D., ... [Published Cardiovascular Business - Aug 13 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 2 reports

HeartWare nabs JenaValve exec Leadley for medical chief | Personnel Moves

by HeartWare International names Dr. Katrin Leadley to be its new chief medical officer following the retirement of Dr. David Hathaway.HeartWare International (NSDQ: HTWR ) said it recruited the former medical chief at JenaValve , Dr. Katrin Leadley, ... [Published MassDevice - Aug 12 2014]
First reported Aug 05 2014 - Updated Aug 05 2014 - 3 reports

HeartWare Presentation At The Canaccord Genuity 34th Annual Growth Conference To Be Webcast

First reported Aug 05 2014 - Updated Aug 05 2014 - 2 reports

Peripheral Vascular Devices - Global Trends, Estimates and Forecasts, 2012-2018

Dublin, Aug. 5, 2014 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/v67qrj/peripheral) has announced the addition of the report to their offering.Global Peripheral Vascular Devices sector forecasts to reach US$5 billion ... [Published Nations Restaurant News - Aug 05 2014]
First reported Aug 04 2014 - Updated Aug 04 2014 - 3 reports

HeartWare International Announces Appointment Of Katrin Leadley, M.D., As Chief Medical Officer

FRAMINGHAM, Mass."Katrin has a wealth of clinical program management experience, and we are confident she will be a great addition to our team," said Doug GodshallDuring her time at JenaValve, Leadley oversaw the company's global clinical programs and ... [Published Bio-Medicine - Aug 04 2014]
First reported Aug 01 2014 - Updated Aug 01 2014 - 1 reports

JPMorgan Chase & Co. Reiterates “Overweight” Rating for HeartWare International (HTWR)

HeartWare International (NASDAQ:HTWR) HeartWare International (NASDAQ:HTWR) traded down 2.20% on Friday, hitting $82.36. 192,814 shares of the company’s stock traded hands. HeartWare International has a one year low of $69.31 and a one year high of $105.84. ... [Published American Banking News - Aug 01 2014]
First reported Jul 31 2014 - Updated Aug 01 2014 - 8 reports

HeartWare celebrates record Q2 sales despite regulatory pushback

HeartWare's Ventricular Assist System--Courtesy of HeartWare InternationalHeartWare International ($HTWR) is facing FDA ire for its ventricular assist system, but regulatory pushback hasn't seemed to put a damper on earnings. The company charted double-digit ... [Published FierceMedicalDevices - Aug 01 2014]

Quotes

...According to news reporting from Leipzig, Germany , by NewsRx journalists, research stated, "The HeartWare ( HeartWare International Inc. Framingham, MA ) ventricular assist device (HVAD) is approved for implantation through a sternotomy with cardiopulmonary bypass."
...for regulatory professionals and to help shape the future of the regulatory profession," said Cecilia Kimberlin, former chairman of the RAPS board. "Service on the board is a rewarding experience-professionally and personally-providing a unique opportunity to lead and serve the global regulatory profession and advance the value and role of RAPS around the globe."
"The patient has completely recovered with good health condition now. In the first three months, the patient must be back to hospital once a month to have medical check to make sure that the heart is working well" Phu was quoted by VNExpress as saying
"It was like a briefing by the chief architect of HDB, but instead it was given by PM."

More Content

All (104) | News (71) | Reports (0) | Blogs (29) | Audio/Video (0) | Fact Sheets (0) | Press Releases (4)
sort by: Date | Relevance
Developing the ‘heartware’ for a Smart Nation [Published Today Online - 6 hours ago]
HeartWare : Reports Outline Cardiology Study Fi... [Published 4 Traders - 12 hours ago]
Biggest Movers in Healthcare Stocks Now – LGND ... [Published InvestorPlace.com - Aug 26 2014]
Music helps develop youth sensibilities, says T... [Published New Sarawak Tribune - Aug 25 2014]
First patient with Heartware artificial heart o... [Published People's Army Newspaper Online - Aug 23 2014]
Biggest Movers in Healthcare Stocks Now – PBYI ... [Published InvestorPlace.com - Aug 23 2014]
Helping to Lead the Regulatory Profession as a ... [Published Regulatory Affairs Professionals Society - Aug 22 2014]
Vietnam successfully carries out first artifici... [Published Namibia Press Agency - Aug 22 2014]
First patient with Heartware artificial heart o... [Published VietnamPlus - Aug 22 2014]
Vietnam successfully carries out first artifici... [Published China.org.cn - Aug 22 2014]
Insider Selling: HeartWare International Direct... [Published American Banking News - Forex - Aug 21 2014]
Insider Selling: Jeffrey Larose Sells 2,179 Sha... [Published American Banking News - Forex - Aug 21 2014]
Hottest Healthcare Stocks Now – THOR GSK ESRX CNC [Published InvestorPlace.com - Aug 21 2014]
HeartWare International Director Robert Bain Th... [Published American Banking News - Aug 20 2014]
Thoratec: High Risk, Higher Reward (68%+ Upside) [Published Seeking Alpha - Aug 19 2014]
10 years of bold moves... and babies [Published Asiaone - Aug 16 2014]
Leading U.K. banker rumored for Glaxo chairman ... [Published FierceBiotech - Aug 15 2014]
Bioscience Managers' first fund achieves 24.7% IRR [Published Australian Life Scientist - Aug 15 2014]
Biggest Movers in Healthcare Stocks Now – ALXN ... [Published InvestorPlace.com - Aug 15 2014]
HeartWare International announces appointment o... [Published Cardiovascular Business - Aug 13 2014]
HeartWare nabs JenaValve exec Leadley for medic... [Published MassDevice - Aug 12 2014]
HeartWare Taps Former Boston Sci Exec as CMO [Published QMED - Aug 12 2014]
Sunshine Heart C-Pulse: A Paradigm Shift In Hea... [Published Seeking Alpha - Aug 11 2014]
12 Top Consensus Stock Holdings From Best 3 Hea... [Published Seeking Alpha - Aug 10 2014]
Hottest Healthcare Stocks Now – ALNY PBH OPK ENDP [Published InvestorPlace.com - Aug 09 2014]
Hottest Healthcare Stocks Now – CRL MDCO QCOR THRX [Published InvestorPlace.com - Aug 07 2014]
Thoratec Down 26% As Earnings And Guidance Disa... [Published Bidness Etc - Aug 07 2014]
HeartWare International appoints Katrin Leadley... [Published Center Watch - Aug 05 2014]
HeartWare Presentation At The Canaccord Genuity... [Published Indianapolis Business Journal - Aug 05 2014]
HeartWare Presentation At The Canaccord Genuity... [Published Bio-Medicine - Aug 05 2014]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
HeartWare Presentation At The Canaccord Genuity... [Published PR Newswire: Health - Aug 05 2014]
FRAMINGHAM, Mass., Aug. 5, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced ...
Forbion Capital to sell Santaris Pharma to Roch... [Published PE Hub Blog - Aug 05 2014]
Forbion Capital Partners has sold biopharmaceutical company Santaris Pharma A/S for $450 million to Roche . The deal is structured with an upfront cash payment of $250 million and additional contingent payments of up to $200 million based on achievement ...
HeartWare International Announces Appointment O... [Published PR Newswire: Health - Aug 04 2014]
FRAMINGHAM, Mass., Aug. 4, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced ...
HeartWare Schedules Second Quarter Conference C... [Published PR Newswire: Financial Services - Jul 17 2014]
FRAMINGHAM, Mass., July 17, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR) has scheduled a conference call to discuss its financial results for the three months ended June 30, 2014, at 8:00 a.m. U.S. Eastern Daylight Time on Thursday, ...
Research and Markets: France Cardiac Assist Dev... [Published Business Wire Professional Services News - Jun 11 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/j2qprz/france_cardiac) has announced the addition of the "France Cardiac Assist Devices Market Outlook to 2020: Key players covered include Thoratec, MAQUET, Teleflex, ...
1 2 3 4 5 6

Press Releases

sort by: Date | Relevance
HeartWare International Reports $70.1 Million I... [Published Financial Services - Jul 31 2014]
HeartWare International Reports $66.5 Million I... [Published Financial Services - May 01 2014]
The Zacks Analyst Blog Highlights:Baidu, Noah H... [Published Financial Services - Mar 19 2014]
HeartWare International Announces Preliminary F... [Published PR Newswire - Jan 14 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.